Serum folate and homocysteine levels are associated with colon tumorigenesis in end-stage renal disease patients

Nutrition and Cancer

Volumn 63, Issue 2, 2011, Pages 202-211

  Kaji, Eisuke ^a   Kato, Jun ^a   Saito, Shunsuke ^a   Harada, Keita ^a   Kuwaki, Kenji ^a   Tatsukawa, Masashi ^a   Morikawa, Tamiya ^a   Hiraoka, Sakiko ^a   Matsushima, Hiroshi ^b   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Shigei Medical Research Institute and Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; COLON CARCINOGENESIS; COLONOSCOPY; CONTROLLED STUDY; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLONIC NEOPLASMS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SERUM;

EID: 79951929509     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2011.523501     Document Type: Article

References (44)

1. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, et al.: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94, 3290-3295, 1997.
2. Kim YI: Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13, 511-519, 2004.
3. Giovannucci E: Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132, 2350S-2355S, 2002.
4. Martinez ME, Henning SM, and Alberts DS: Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 79, 691-697, 2004. (Pubitemid 41103916)
5. Baron JA, Sandler RS, Haile RW,Mandel JS, Mott LA, et al.: Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 90, 57-62, 1998. (Pubitemid 28078082)
6. Bird CL, Swendseid ME,Witte JS, Shikany JM, Hunt IF, et al.: Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 4, 709-714, 1995.
7. SanjoaquinMA, Allen N, Couto E, Roddam AW, and Key TJ: Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113, 825-828, 2005 (Pubitemid 40101266)
8. Glynn SA, Albanes D, Pietinen P, Brown CC, Rautalahti M, et al.: Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 5, 487-494, 1996. (Pubitemid 26235013)
9. Ma J, Stampfer MJ, Giovannucci E, Artigas CA, Hunter DJ, et al.: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57, 1098-1102, 1997. (Pubitemid 27138608)
10. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, et al.: Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 79, 1917-1921, 1999.
11. Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, et al.: Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine- treated rats. Cancer Res 52, 5002-5006, 1992.
12. Wargovich MJ, Chen CD, JimenezA, Steele VE,Velasco M, et al.:Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5, 355-360, 1996. (Pubitemid 26139118)
13. Kim YI: Role of folate in colon cancer development and progression. J Nutr 133, 3731S-3739S, 2003.
14. Kim YI, Salomon RN, Cook FG, Choi SW, Smith DE, et al.: Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39, 732-740, 1996. (Pubitemid 26426477)
15. Kim YI: Folate, Colorectal carcinogenesis, and dna methylation: lessons from animal studies. Environ Mol Mutagen 44, 10-25, 2004.
16. Richard K, Leu L, Young GP, andMcIntosh GH: Folate deficiency reduces the development of colorectal cancer in rats. Carcinogenesis 21, 2261-2265, 2000. (Pubitemid 32049233)
17. Min mouse. Cancer Res 60, 5434-5440, 2000.
18. Cole BF, Baron JA, Sandler RS, Heile RW, Ahnen DJ, et al.: Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297, 2351-2359, 2007. (Pubitemid 46883748)
19. Jacques PF, Bostom AG,Williams RR, Ellison C, Eckfeldt JH, et al.: Relation between folate status, a commonmutation inmethylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9, 1996. (Pubitemid 26006560)
20. Ping Yi, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, et al.: Increase in plasma homocysteine associated with parallel increases in plasma s-adenosylhomocysteine and lymphocyte dna hypomethylation. J Biol Chem 275, 29318-29323, 2000. (Pubitemid 32043802)
21. Loehrer FMT, Tschöpl M, Angst CP, Litynski P, Jager K, et al.: Disturbed ratio of erythrocyte and plasma S-adenosylmethionine:S- adenosylhomocysteine in peripheral arterial occlusive disease. Atherosclerosis 154, 147-154, 2001. (Pubitemid 32008575)
22. BedfordMT and van Helden PD: Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res 47, 5274-5276, 1987.
23. Goelz SE, Vogelstein B, Hamilton SR, and Feinberg AP: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187-190, 1985. (Pubitemid 15117274)
24. Feinberg AP, Gehrke CW, Kuo KC, and Ehrlich M: Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48, 1159-1161, 1998.
25. Vamvakas S, Bahner U, and Heidland A: Cancer in end-stage renal disease: potential factors involved. Am J Nephrol 18, 89-95, 1998. (Pubitemid 28161811)
26. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, et al.: Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354, 93-99, 1999. (Pubitemid 29313142)
27. Lee S,Wasserberg N, Petrone P, Rosca J, Selby R, et al.: The prevalence of colorectal neoplasia in patients with end-stage renal disease: a case-control study. Int J Colorectal Dis 23, 47-51, 2008. (Pubitemid 350142359)
28. Bostom AG and Lathrop L: Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52, 10-20, 1997. (Pubitemid 27321809)
29. Gopalswamy N, Shenoy VN, Choudhry U, Markert RJ, Peace N, et al.: Is in vivo measurement of size of polyps during colonoscopy accurate? Gastrointest Endosc 46, 497-502, 1997.
30. Peipins LA and Sandler RS: Epidemiology of colorectal adenomas. Epidemiol Rev 16, 273-297, 1994.
31. Neugut AI, Jacobson JS, and DeVivo I: Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2, 159-176, 1993.
32. Heinz J, Domrose U,Westphal S, Luley C, Neumann KH, et al.:Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes. Nephrology 13, 384-389, 2008.
33. The Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke. JAMA 288, 2015-2022, 2002.
34. Selhub J: Homocysteine metabolism. Annu Rev Nutr 19, 217-246, 1999.
35. Finkelstein JD and Martin JJ: Homocysteine. Int J Biochem Cell Biol 32, 385-389, 2000. (Pubitemid 30101618)
36. min/+ mice. Gut Online First, 2009.
37. Kim YI: Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51, 267-292, 2007.
38. Lindzon GM, Medline A, Sohn KJ, Depeint F, Croxford R, et al.: Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci. Carcinogenesis 30, 1536-1543, 2009.
39. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, et al.: Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 101, 432-435, 2009.
40. Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, et al.: Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302, 2119-2126, 2009.
41. Guelpen BV, Hultdin J, Johansson I, Hallmans G, Stenling R, et al.: Low folate levels may protect against colorectal cancer. Gut 55, 1461-1466, 2006. (Pubitemid 44476792)
42. Kim YI: Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55, 1387-1389, 2006.
43. Chen J, Giovannucci EL, and Hunter DJ: MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 129, 560S-564S, 1999.
44. Ulrich CM and Potter JD: Folate and cancer-timing is everything. JAMA 297, 2408-2409, 2007.